Impact of Monetary Incentives on Adherence to Referral for Screening Chest X-rays after Syringe Exchange-Based Tuberculin Skin Testing

Journal of Urban Health

Volumn 80, Issue 3, 2003, Pages 428-437

  Perlman, David C ^a,b   Friedmann, Patricia ^b   Horn, Leslie ^a   Nugent, Anne ^b   Schoeb, Veronika ^a   Carey, Jeanne ^a   Salomon, Nadim ^a   Des Jarlais, Don C ^b  

^a Department of Medicine ^*  (United States)

^b BETH ISRAEL MEDICAL CENTER   (United States)

Author keywords

Adherence; Drug users; Incentives; Tuberculosis

Indexed keywords

ADULT; ARTICLE; CONFIDENCE INTERVAL; CONTROLLED STUDY; CORRELATION ANALYSIS; COST EFFECTIVENESS ANALYSIS; EVALUATION; FEMALE; HEALTH PROGRAM; HEALTH PROMOTION; HUMAN; INTRAVENOUS DRUG ABUSE; MAJOR CLINICAL STUDY; MALE; MONEY; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; PATIENT COMPLIANCE; PATIENT REFERRAL; PRIORITY JOURNAL; SCREENING TEST; STATISTICAL MODEL; SYRINGE; THORAX RADIOGRAPHY; TUBERCULIN TEST; TUBERCULOSIS; UNITED STATES; ECONOMICS; LUNG; LUNG TUBERCULOSIS; MASS SCREENING; MICROBIOLOGY; MIDDLE AGED; MOTIVATION; PREVENTIVE HEALTH SERVICE; RADIOGRAPHY; STATISTICS; SUBSTANCE ABUSE; UTILIZATION REVIEW;

ADULT; FEMALE; HUMANS; LOGISTIC MODELS; LUNG; MALE; MASS SCREENING; MIDDLE AGED; MOTIVATION; NEEDLE-EXCHANGE PROGRAMS; NEW YORK CITY; PATIENT COMPLIANCE; SUBSTANCE ABUSE, INTRAVENOUS; TUBERCULIN TEST; TUBERCULOSIS, PULMONARY;

EID: 0142244527     PISSN: 10993460     EISSN: None     Source Type: Journal    
DOI: 10.1093/jurban/jtg044     Document Type: Article

References (24)

1. Reichman LB, Felton CP, Edsall JR. Drug dependence, a possible new risk factor for tuberculosis disease. Arch Intern Med. 1979;139:337-339.
2. Friedman LN, Sullivan GM, Bevilaqua RP, Loscos R. Tuberculosis screening in alcoholics and drug addicts. Am Rev Respir Dis. 1987;136:1188-1192.
3. Perlman DC, Salomon N, Perkins MP, Yancovitz S, Paone D, Des Jarlais DC. Tuberculosis in drug users. Clin Infect Dis. 1995;21:1253-1264.
4. National Consensus Development Panel on Effective Treatment of Opiate Addiction. Effective medical treatment of opiate addiction. JAMA. 1998;280:1936-1943.
5. Perlman DC, Perkins MP, Salomon N, Kochems L, Des Jarlais DC, Paone D. Tuberculosis screening at a syringe exchange program. Am J Public Health. 1997;87:862-863.
6. Fitzgerald JM, Patrick DM, Strathdee S, et al. Use of incentives to increase compliance for TB screening in a population of intravenous drug users. Vancouver Injection Drug Users Study Group. Int J Tuberc Lung Dis. 1999;3:153-155.
7. Riley ED, Vlahov D, Huettner S, Beilenson P, Bonds M, Chaisson RE. Characteristics of injection drug users who utilize tuberculosis services at sites of the Baltimore city needle exchange program. J Urban Health. 2002;79:113-127.
8. Centers for Disease Control and Prevention update: syringe exchange programs-United States, 1998. MMWR Morb Mortal Wkly Rep. 2001;50:384-387.
9. Centers for Disease Control and Prevention. Targeted tuberculin testing and treatment of latent tuberculosis infection. MMWR Morb Mortal Wkly Rep. 2000;249(RR-6):1-51.
10. Sbarbaro JA. To seek, find, and yet fail. Am Rev Respir Dis. 1987;136:1072-1073.
11. Perlman DC, Gourevitch MN, Trinh C, Salomon N, Horn L, Des Jarlais DC. Cost-effectiveness of tuberculosis screening and observed preventive therapy for active drug injectors at a syringe-exchange program. J Urban Health. 2001;78:550-567.
12. Salomon N, Perlman DC, Friedmann P, Ziluck V, Des Jarlais DC. Prevalence and risk factors for positive tuberculin skin tests among active drug users at a syringe exchange program. Int J Tuberc Lung Dis. 2000;4:47-54.
13. Umbricht-Schneiter A, Ginn DH, Pabst KM, Bigelow GE. Providing medical care to methadone patients: referral versus on-site care. Am J Public Health. 1994;84:207-210.
14. Batki SL, Gruber VA, Bradley JM, Bradley M, Delucchi K. A controlled trial of methadone treatment combined with directly observed isoniazid for tuberculosis prevention in injection drug users. Drug Alcohol Depend. 2002;66:283-293.
15. Trubatch BN, Fisher DG, Cagle HH, Fenaughty AM. Vaccination strategies for targeted and difficult-to- access groups. Am J Public Health. 2000;90:447.
16. Des Jarlais DC, Fisher D, Clark J, et al. Providing HBV vaccination to injecting drug users: referral to health clinics and on-site at a syringe exchange program. Am J Public Health. 2001;91:1791-1792.
17. Gourevitch M, Alcabes P, Wasserman WC, Arno PS. Cost-effectiveness of directly observed chemoprophylaxis among drug users at risk for tuberculosis. Int J Tuberc Lung Dis. 1998;2:531-540.
18. Lorvick J, Thompson S, Edlin BR, Kral AH, Lifson AR, Watters JK. Incentives and accessibility: a pilot study to promote adherence to TB prophylaxis in a high-risk community. J Urban Health. 1999;76:461-467.
19. Malotte CK, Rhodes F, Mais KE. Tuberculosis screening and compliance with return for skin test reading among active drug users. Am J Public Health. 1998;88:792-796.
20. Chaisson RE, Keruly JC, McAvinue S, Gallant JE, Moore RD. Effects of an incentive and education program on return rates for PPD test reading in patients with HIV infection. J Acquir Immune Defic Syndr Hum Retrovirol. 1996;11:455-459.
21. Faden RR, Beauchamp TL. A History and Theory of Informed Consent. New York, NY: Oxford University Press; 1986.
22. Deren S, Stephens R, Davis WR, Feucht TE, Tortu S. The impact of providing incentives for attendance at AIDS prevention sessions. Public Health Rep. 1994;109:548-554.
23. Tashler CL, Bartholomae S. The recruitment of normal healthy volunteers: a review of the literature on the use of financial incentives. J Clin Pharmacol. 2002;42:365-375.
24. Lorvick J, Edlin BR. Effectiveness of incentives in health interventions: what do we know from the literature? Paper presented at: 128th Annual Meeting of the American Public Health Association; Session 6014.0; November 16, 2000. Available at: http://apha/confex.com/apha/128am/techprogram/session_1955.htm. Accessed June 16, 2003.